Anna P. Krasnoshchekova

Anna P. Krasnoshchekova

Auto-generated profile, based on publicly available information

Anna P. Krasnoshchekova

Sechenov First Moscow State Medical University, Moscow, Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
AYAndrey Yaroshetskiy
Andrey Yaroshetskiy
ZMZamira M. Merzhoeva
Zamira M. Merzhoeva
NTNatalia A. Tsareva
Natalia A. Tsareva
НТНаталья Трушенко
Наталья Трушенко
GNGalia S. Nuralieva
Galia S. Nuralieva
SASergey Avdeev
Sergey Avdeev
Background: Data on the efficacy of non-invasive ventilation (NIV) after progression of respiratory failure in patients who have already received oxygen therapy, or CPAP outside ICU is limited. The study aimed to find predictors of NIV failure based on breathing pattern, gas exchange, and accessory respiratory muscles evaluation in patients who progressed to moderate-to-severe COVID-19 ARDS. Methods: This was a prospective observational study in patients with moderate-to-severe COVID-19-ARDS on NIV (n = 80) admitted to COVID-ICU of Sechenov University. The combined success rate for conventional oxygen and CPAP outside ICU was 78.6% (440 of 560 patients). The primary endpoints were intubation rate and mortality. We measured respiratory rate, exhaled tidal volume (Vte), mean peak inspiratory flow (PIF), inspiratory time (Ti), PaO2, SpO2, end-tidal carbon dioxide (PETCO2), and Patrick score, and calculated ROX index, PaO2/FiO2, ventilatory ratio, and alveolar dead space (Vdalv/Vt) on Days 1, 3, 5, 7, 10, and 14. For all significant differences between NIV success and failure groups in measured data, we performed ROC analysis. Results: NIV failure rate in ICU after deterioration of respiratory failure outside ICU was 71.3% (n = 57). Patients with the subsequent NIV failure were older at inclusion, more frail, had longer duration of disease before ICU admission, and higher rate of CPAP use outside ICU. ROC-analysis revealed that the following respiratory parameters after 48 h of NIV can serve as a predictors for NIV failure in moderate-to-severe COVID-19-associated ARDS: PaO2/FiO2 < 112 mmHg (AUROC 0.90 (0.93–0.97), p < 0.0001); PETCO2 < 19.5 mmHg (AUROC 0.84 (0.73–0.94), p < 0.0001); VDalv/VT > 0.43 (AUROC 0.78 (0.68–0.90), p < 0.0001); ROX-index < 5.02 (AUROC 0.89 (0.81–0.97), p < 0.0001); Patrick score > 2 points (AUROC 0.87 (0.78–0.96), p = 0.006). Conclusion: In patients who progressed to moderate-to-severe COVID-19-ARDS probability of NIV success rate was about 1/3. Prediction of the NIV failure can be made after 48 h based on ROX index < 5.02, PaO2/FiO2 < 112 mmHg, PETCO2 < 19.5 mmHg, and Patrick score > = 2. Trial registration: ClinicalTrials.gov identifier: NCT04667923, registered on 16/12/2020.

4 March 2022 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
AYAndrey Yaroshetskiy
Andrey Yaroshetskiy
SASergey Avdeev
Sergey Avdeev
MPMikhail E. Politov
Mikhail E. Politov
PNPavel V. Nogtev
Pavel V. Nogtev
VBVictoria G. Beresneva
Victoria G. Beresneva
AYAndrey G. Yavorovskiy
Andrey G. Yavorovskiy
Background: Data on the lung respiratory mechanics and gas exchange in the time course of COVID-19-associated respiratory failure is limited. This study aimed to explore respiratory mechanics and gas exchange, the lung recruitability and risk of overdistension during the time course of mechanical ventilation. Methods: This was a prospective observational study in critically ill mechanically ventilated patients (n = 116) with COVID-19 admitted into Intensive Care Units of Sechenov University. The primary endpoints were: «optimum» positive end-expiratory pressure (PEEP) level balanced between the lowest driving pressure and the highest SpO2 and number of patients with recruitable lung on Days 1 and 7 of mechanical ventilation. We measured driving pressure at different levels of PEEP (14, 12, 10 and 8 cmH2O) with preset tidal volume, and with the increase of tidal volume by 100 ml and 200 ml at preset PEEP level, and calculated static respiratory system compliance (CRS), PaO2/FiO2, alveolar dead space and ventilatory ratio on Days 1, 3, 5, 7, 10, 14 and 21. Results: The «optimum» PEEP levels on Day 1 were 11.0 (10.0–12.8) cmH2O and 10.0 (9.0–12.0) cmH2O on Day 7. Positive response to recruitment was observed on Day 1 in 27.6% and on Day 7 in 9.2% of patients. PEEP increase from 10 to 14 cmH2O and VT increase by 100 and 200 ml led to a significant decrease in CRS from Day 1 to Day 14 (p < 0.05). Ventilatory ratio was 2.2 (1.7–2,7) in non-survivors and in 1.9 (1.6–2.6) survivors on Day 1 and decreased on Day 7 in survivors only (p < 0.01). PaO2/FiO2 was 105.5 (76.2–141.7) mmHg in non-survivors on Day 1 and 136.6 (106.7–160.8) in survivors (p = 0.002). In survivors, PaO2/FiO2 rose on Day 3 (p = 0.008) and then between Days 7 and 10 (p = 0.046). Conclusion: Lung recruitability was low in COVID-19 and decreased during the course of the disease, but lung overdistension occurred at «intermediate» PEEP and VT levels. In survivors gas exchange improvements after Day 7 mismatched CRS. Trial registration: ClinicalTrials.gov, NCT04445961. Registered 24 June 2020—Retrospectively registered.

23 August 2025 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
AYAndrey Yaroshetskiy
Andrey Yaroshetskiy
AKAnna P. Krasnoshchekova
Anna P. Krasnoshchekova
FTFedor D. Tkachenko
Fedor D. Tkachenko
ARAlina V. Rubashchenko
Alina V. Rubashchenko
DZDaniil D. Zubarev
Daniil D. Zubarev
SASergey Avdeev
Sergey Avdeev
Background: High-flow nasal cannula is widespread in patients with hypoxemic and hypercapnic respiratory failure, but physiological data concerning influence of the combination of breathing pattern, preset flow rate (PFR), and inspiratory oxygen fraction (FDO2) on end-expiratory pressure (EEP), capnogram, oxygram, and exhaled tidal volume (VTe) remains insufficient. Methods: The study included 20 healthy subjects with 12 combinations of PFR (30–60-80 L/min) and FDO2 (40–60-80–100%) multiplied by 4 breathing patterns: mouth closed (CM), mouth open (OM), and combination of the CM and OM with hyperpnea (HCM and HOM). Pressure, capnogram, oxygram were measured from hypopharyngeal catheter, VTe, and subject’s comfort were assessed. Results: Inspiratory oxygen fraction (FiO2) were close to FDO2 at the PFR of 30 L/min (CM), and 60 L/min (HCM). FiO2 during the OM and HOM were much less than FDO2, variable and unpredictable. PFR of 60 L/min was sufficient to keep FiO2 close to FDO2 during the CM and HCM. End-expiratory carbon dioxide (FECO2) decreased with an increase in the PFR and FDO2, reaching 1.4 (1.1–1.7)% at FDO2 100% and PFR of 80 L/min. EEP had grown a lot with the PFR increase and were highly variable reaching 11.1 (7.7–14.8) cmH2O at the PFR of 80 L/min. VTe at the PFR of 60 and 80 L/min were 948.0 (715.0–1204.8) and 948.0 (869.0–1422.0) ml, respectively. PFR of 60 L/min and 80 L/min were associated with discomfort. Conclusion: HCM, OM, and HOM in healthy subjects decreased FiO2 and FECO2 (more pronounced during OM and HOM). HFNC within the CM and HCM provided flow-dependent CPAP-effects over a wide range and could be associated with lung hyperinflation. An excessive PFR led to discomfort. Trial registration: ClinicalTrials.gov identifier: NCT06189716, registered on 19/12/2023.

31 January 2023 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
BAB.A. Akselrod
B.A. Akselrod
AGArtem Viktorovich Gubko
Artem Viktorovich Gubko
ODO.V. Dymova
O.V. Dymova
DGD.A. Guskov
D.A. Guskov
KGK.V. Gubko
K.V. Gubko
AKA.P. Krasnoshchekova
A.P. Krasnoshchekova
Objective. To identify the correlations between volemic status and serum pro-ANP. Material and methods. There were 30 cardiac surgical patients. Hemodynamic monitoring included stroke volume variation, stroke volume, and cardiac output. Serum pro-ANP and volemic status were intraoperatively analyzed at 8 stages including Teboul tests. Results. Serum pro-ANP at the end of surgery was 2.27 [1.5; 2.5] times higher compared to the baseline value. At the beginning of surgery serum pro-ANP was 102 [89; 185] pg/ml, at the end of surgery — 276 [171; 324] pg/ml. The majority of patients were non-responders according to Teboul test after induction of anesthesia and at the end of surgery. Serum pro-ANP was similar before and after functional tests. Stroke volume variation was 12% [8; 15] at the end of cardiopulmonary bypass and 5-10% in other points. Cumulative fluid balance was 1830 [1440; 2400] ml. No correlations between infusion rate, volume and serum pro-ANP were observed. Conclusion. Serum pro-ANP increased after cardiopulmonary bypass regardless of type and duration of surgery. No correlations between functional tests, hemodynamics, fluid balance and serum pro-ANP were detected.

30 October 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
ZMZ. M. Merzhoeva
Z. M. Merzhoeva
AYAndrey Yaroshetskiy
Andrey Yaroshetskiy
SSS. A. Savko
S. A. Savko
AKA. P. Krasnoshchekova
A. P. Krasnoshchekova
Irina MandelIrina Mandel
Irina Mandel
SASergey Avdeev
Sergey Avdeev
INTRODUCTION: Therapy of COVID-19 patients with progressive lung damage after the use of glucocorticosteroids (GCS) and interleukin-6 inhibitors (IIL-6) has not yet been developed. OBJECTIVE: Assessment of the effectiveness of cyclosporine A in patients with COVID-19 with progression of lung damage and hypoxemic acute respiratory failure, who received therapy with GCS and IIL-6. MATERIALS AND METHODS: A retrospective cohort propensity-score matched analysis (n = 98). Cyclosporine A was prescribed in the first 72–96 hours after IIL-6 administration when the patient's condition worsened. The patients of comparison group corresponded to the study group, but did not receive cyclosporine A therapy. The primary end point was in-hospital mortality. Secondary endpoints — duration of hospitalization, number of patients admitted to the intensive care unit (ICU), need for respiratory support. RESULTS: Mortality was 12 (22) % in the cyclosporine group and 27 (61) % in the comparison group, р = 0.001 (hazard ratio [HR] 2.00 (1.12–3.48), р = 0.018), ICU admission rate 14 (26) % vs 29 (66) %, р = 0.001, respectively. In the cyclosporine group on day 7 CT-4, there were 26 % of patients vs 52 % in the control group, р = 0.014, the need for respiratory support (37 % vs 63.6 %, р = 0.011); saturation 88 % (82–93) vs 80 % (70–86), р = 0.001, respectively. The need for respiratory support at day 11 after IIL-6 increased the likelihood of death (HR 7.10 (2.5–20), р = 0.001). Risk factors for death: age over 57.5 years, body mass index over 30 kg/m2, hemoglobin oxygen saturation below 85.5 % on the day of IIL-6 application. Duration of hospitalization was 18.5 (14–24) days vs 18 (12–24) days, р = 0.778. CONCLUSIONS: Cyclosporine A in addition to GCS and IIL-6 for COVID-19 therapy may reduce mortality, ICU admissions, and respiratory support requirements.

21 May 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
БАБ. А. Аксельрод
Б. А. Аксельрод
ODO. V. Dymova
O. V. Dymova
AGArtem Viktorovich Gubko
Artem Viktorovich Gubko
AKA. P. Krasnoshchekova
A. P. Krasnoshchekova
ДГД. А. Гуськов
Д. А. Гуськов
OKO. S. Kulinchenko
O. S. Kulinchenko
Aim. This study aims to assess the association between levels of biomarkers and postoperative complications in patients after thoracic and thoracoabdominal aortic reconstruction.Material and methods. This study included 132 patients. The most of them underwent ascending aortic and aortic arch reconstruction (65 and 57, respectively).The concentrations of proadrenomedullin, presepsin, procalcitonin, troponin I and N-terminal brain natriuretic peptide were measured before induction anesthesia, at the end of the surgical operation and in 6 hours after surgery.Results. 69 patients had postoperative complications. Among them, inflammatory (27,3%) and cardiovascular complications (12,1%) prevailed. At the end of the surgical operation, the levels of the biomarkers in patients without postoperative complications and with postoperative complications were for presepsin 326 [206; 451] и 620 [332; 829] p459,5 (odds ratio (OR) 6,84, 95% confidence interval (CI): 3,14-14,87) or proadrenomedullin >0,788 (OR 5,47, 95% CI: 1,52-19,68) are associated with the increased risk of postoperative complications. The level of presepsin >519,5 pg/ml at the end of the surgical operation (OR 4,55, 95% CI: 1,97-10,47) is associated with the increased risk of inflammatory complications. Regarding the prognosis of the risk of prolonged cardiotonic drug infusions, threshold values for troponin were >1,04 at the end of the surgical operation (sensitivity 75%, specificity 71,3%, AUC 0,785), >1,57 in 6 hours after surgery (sensitivity 81,3%, specificity 71,6%, AUC 0,794).Conclusion. High levels of presepsin at the end of the surgical operation may be useful to predict the postoperative complications in patients who underwent the aortic surgery however, the low levels of presepsin do not exclude the development of postoperative complications. The increased level of troponin I at the end of the surgical operation and in 6 hours after surgery can be a predictor of the need for cardiotonic support in the postoperative period.